InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Bausch Health Companies Inc.

BHC Clue Score43
Quebec, Canada Fiscal year ends December CIK 0000885590
$6.04 +0.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.04 −78.26% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue9.67Operating income−0.57Net income−2.41EPS, diluted−6.94Fiscal year 2017Revenue8.72 −9.8%Operating income0.10Net income2.40EPS, diluted6.83Fiscal year 2018Revenue8.38 −3.9%Operating income−2.38Net income−4.14 −272.4%EPS, diluted−11.81 −272.9%Fiscal year 2019Revenue8.60 +2.6%Operating income−0.20Net income−1.79EPS, diluted−5.08Fiscal year 2020Revenue8.03 −6.7%Operating income0.68Net income−0.56EPS, diluted−1.58Fiscal year 2021Revenue8.43 +5.1%Operating income0.45Net income−0.95EPS, diluted−2.64Fiscal year 2022Revenue8.12 −3.7%Operating income0.45Net income−0.23EPS, diluted−0.62Fiscal year 2023Revenue8.76 +7.8%Operating income0.96Net income−0.59EPS, diluted−1.62Fiscal year 2024Revenue9.63 +9.9%Operating income1.55Net income−0.05EPS, diluted−0.13Fiscal year 2025Revenue10.27 +6.7%Operating income1.81Net income0.16EPS, diluted0.42
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 9.67 8.72 8.38 8.60 8.03 8.43 8.12 8.76 9.63 10.27
Growth −9.8% −3.9% +2.6% −6.7% +5.1% −3.7% +7.8% +9.9% +6.7%
Operating income −0.57 0.10 −2.38 −0.20 0.68 0.45 0.45 0.96 1.55 1.81
Net income −2.41 2.40 −4.14 −1.79 −0.56 −0.95 −0.23 −0.59 −0.05 0.16
Growth −272.4%
EPS, diluted −6.94 6.83 −11.81 −5.08 −1.58 −2.64 −0.62 −1.62 −0.13 0.42
Growth −272.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−5.9%Net margin−24.9%Free cash flow margin19.1%Fiscal year 2017Operating margin1.2%Net margin27.6%Free cash flow margin24.3%Fiscal year 2018Operating margin−28.4%Net margin−49.5%Free cash flow margin16.0%Fiscal year 2019Operating margin−2.4%Net margin−20.8%Free cash flow margin14.3%Fiscal year 2020Operating margin8.4%Net margin−7.0%Free cash flow margin10.1%Fiscal year 2021Operating margin5.3%Net margin−11.2%Free cash flow margin13.7%Fiscal year 2022Operating margin5.6%Net margin−2.8%Free cash flow margin−11.6%Fiscal year 2023Operating margin11.0%Net margin−6.8%Free cash flow margin9.3%Fiscal year 2024Operating margin16.1%Net margin−0.5%Free cash flow margin13.1%Fiscal year 2025Operating margin17.7%Net margin1.5%Free cash flow margin9.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −5.9% 1.2% −28.4% −2.4% 8.4% 5.3% 5.6% 11.0% 16.1% 17.7%
Net margin −24.9% 27.6% −49.5% −20.8% −7.0% −11.2% −2.8% −6.8% −0.5% 1.5%
Free cash flow margin 19.1% 24.3% 16.0% 14.3% 10.1% 13.7% −11.6% 9.3% 13.1% 9.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow2.09Capital expenditure−0.24Free cash flow1.85Buybacks0.00Fiscal year 2017Operating cash flow2.29Capital expenditure−0.17Free cash flow2.12 +14.4%Buybacks0.00Fiscal year 2018Operating cash flow1.50Capital expenditure−0.16Free cash flow1.34 −36.6%Fiscal year 2019Operating cash flow1.50Capital expenditure−0.27Free cash flow1.23 −8.4%Fiscal year 2020Operating cash flow1.11Capital expenditure−0.30Free cash flow0.81 −34.3%Fiscal year 2021Operating cash flow1.43Capital expenditure−0.27Free cash flow1.16 +43.0%Fiscal year 2022Operating cash flow−0.73Capital expenditure−0.22Free cash flow−0.95 −181.8%Fiscal year 2023Operating cash flow1.03Capital expenditure−0.22Free cash flow0.82Fiscal year 2024Operating cash flow1.60Capital expenditure−0.34Free cash flow1.26 +54.2%Fiscal year 2025Operating cash flow1.40Capital expenditure−0.40Free cash flow1.00 −20.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 2.09 2.29 1.50 1.50 1.11 1.43 −0.73 1.03 1.60 1.40
Capital expenditure −0.24 −0.17 −0.16 −0.27 −0.30 −0.27 −0.22 −0.22 −0.34 −0.40
Free cash flow 1.85 2.12 1.34 1.23 0.81 1.16 −0.95 0.82 1.26 1.00
Growth +14.4% −36.6% −8.4% −34.3% +43.0% −181.8% +54.2% −20.4%
Buybacks 0.00 0.00 n/a n/a n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.54Total debt29.85Net cash (debt)−29.30Shareholders’ equity3.15Debt to equity9.47Fiscal year 2017Cash0.72Total debt25.44Net cash (debt)−24.72Shareholders’ equity5.85Debt to equity4.35Fiscal year 2018Cash0.72Total debt24.31Net cash (debt)−23.58Shareholders’ equity2.73Debt to equity8.89Fiscal year 2019Cash3.24Total debt25.90Net cash (debt)−22.65Shareholders’ equity1.06Debt to equity24.36Fiscal year 2020Cash0.61Total debt23.93Net cash (debt)−23.32Shareholders’ equity0.54Debt to equity44.72Fiscal year 2021Cash0.58Total debt22.65Net cash (debt)−22.07Shareholders’ equity−0.11Fiscal year 2022Cash0.56Total debt20.77Net cash (debt)−20.20Shareholders’ equity−0.69Fiscal year 2023Cash0.95Total debt22.39Net cash (debt)−21.44Shareholders’ equity−1.02Fiscal year 2024Cash1.18Total debt21.62Net cash (debt)−20.44Shareholders’ equity−1.28Fiscal year 2025Cash1.31Total debt20.82Net cash (debt)−19.51Shareholders’ equity−0.55
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.54 0.72 0.72 3.24 0.61 0.58 0.56 0.95 1.18 1.31
Total debt 29.85 25.44 24.31 25.90 23.93 22.65 20.77 22.39 21.62 20.82
Net cash (debt) −29.30 −24.72 −23.58 −22.65 −23.32 −22.07 −20.20 −21.44 −20.44 −19.51
Shareholders’ equity 3.15 5.85 2.73 1.06 0.54 −0.11 −0.69 −1.02 −1.28 −0.55
Debt to equity 9.47 4.35 8.89 24.36 44.72 n/a n/a n/a n/a n/a

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
9.67 8.72 8.38 8.60 8.03 8.43 8.12 8.76 9.63 10.27
Growth −9.8% −3.9% +2.6% −6.7% +5.1% −3.7% +7.8% +9.9% +6.7%
2.81 2.58 2.47 2.55 2.37 2.62 2.63 2.92 3.30 3.44
−0.57 0.10 −2.38 −0.20 0.68 0.45 0.45 0.96 1.55 1.81
Growth −2,437.3% −33.4% +0.9% +112.1% +60.5% +17.3%
−2.44 −1.74 −4.15 −1.84 −0.93 −1.02 −0.13 −0.39 0.17 0.37
−0.03 −4.15 −0.01 −0.05 −0.38 −0.09 0.08 0.22 0.24 0.25
−2.41 2.40 −4.14 −1.79 −0.56 −0.95 −0.23 −0.59 −0.05 0.16
Growth −272.4%
Per share
−6.94 6.86 −11.81 −5.08 −1.58 −2.64 −0.62 −1.62 −0.13 0.42
−6.94 6.83 −11.81 −5.08 −1.58 −2.64 −0.62 −1.62 −0.13 0.42
Growth −272.9%
347.3 350.2 351.3 352.1 355.0 358.9 362.0 364.9 368.0 370.9
347.3 351.8 351.3 352.1 355.0 358.9 362.0 364.9 368.0 375.0
Growth +1.3% −0.1% +0.2% +0.8% +1.1% +0.9% +0.8% +0.8% +1.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 5.0% a year over five years.
  • The diluted share count rose 5.6% in five years, which is dilution.
  • Operating margin is up 9.2 points on five years ago, at 17.7%.
  • A net loss in 8 of 10 years on file.